Use of Cosmetic Facial Injectables After Facial Aesthetic Surgery.
Abstract
[BACKGROUND] Over the last 2 decades, both invasive and minimally invasive aesthetic procedures have proliferated. Aesthetic surgeons often recommend injectable treatments after cosmetic facial surgery for multiple reasons. However, literature is lacking on how cosmetic surgery affects postoperative facial injectable use.
[OBJECTIVES] The aim of this study was to identify predictors of facial injectable use after cosmetic facial surgery.
[METHODS] All adult patients operated on by a single surgeon between 2013 and 2021 were retrospectively reviewed. Patients who had any of the following cosmetic facial surgeries were included: rhytidectomy, blepharoplasty, rhinoplasty, or genioplasty. Patient demographics, clinical history, intraoperative factors, and use of cosmetic facial injectables (neurotoxin, facial fillers, deoxycholic acid, poly-l-lactic acid) were recorded.
[RESULTS] A total of 227 patients who underwent facial cosmetic surgery were reviewed, of whom 158 were included. Of these, 89 patients had rhytidectomy (56.3%), 112 had blepharoplasty (70.9%), 28 had rhinoplasty (17.7%), and 7 had genioplasty (4.4%). Injectables were administered to 44.3% of patients after their surgery (n = 73), compared with only 17.7% before surgery (n = 28) (P < 0.001). The most common postoperative injectables were neurotoxins (48.5%) and facial fillers (46.0%), followed by deoxycholic acid (2.7%) and poly-l-lactic acid (2.7%). Multivariate regression revealed factors positively correlated with future injectable use were index blepharoplasty or rhinoplasty, and history of preoperative neurotoxin injection (P < 0.05).
[CONCLUSIONS] Cosmetic facial injectables are an important consideration in achieving and maintaining optimal facial aesthetics. Their use, especially neurotoxins and facial fillers, has increased among patients postoperatively. These results highlight the contribution of injectable procedures in the context of multidimensional care for augmenting facial aesthetics.
[OBJECTIVES] The aim of this study was to identify predictors of facial injectable use after cosmetic facial surgery.
[METHODS] All adult patients operated on by a single surgeon between 2013 and 2021 were retrospectively reviewed. Patients who had any of the following cosmetic facial surgeries were included: rhytidectomy, blepharoplasty, rhinoplasty, or genioplasty. Patient demographics, clinical history, intraoperative factors, and use of cosmetic facial injectables (neurotoxin, facial fillers, deoxycholic acid, poly-l-lactic acid) were recorded.
[RESULTS] A total of 227 patients who underwent facial cosmetic surgery were reviewed, of whom 158 were included. Of these, 89 patients had rhytidectomy (56.3%), 112 had blepharoplasty (70.9%), 28 had rhinoplasty (17.7%), and 7 had genioplasty (4.4%). Injectables were administered to 44.3% of patients after their surgery (n = 73), compared with only 17.7% before surgery (n = 28) (P < 0.001). The most common postoperative injectables were neurotoxins (48.5%) and facial fillers (46.0%), followed by deoxycholic acid (2.7%) and poly-l-lactic acid (2.7%). Multivariate regression revealed factors positively correlated with future injectable use were index blepharoplasty or rhinoplasty, and history of preoperative neurotoxin injection (P < 0.05).
[CONCLUSIONS] Cosmetic facial injectables are an important consideration in achieving and maintaining optimal facial aesthetics. Their use, especially neurotoxins and facial fillers, has increased among patients postoperatively. These results highlight the contribution of injectable procedures in the context of multidimensional care for augmenting facial aesthetics.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | rhinoplasty
|
코성형술 | dict | 3 | |
| 시술 | blepharoplasty
|
안검성형술 | dict | 3 | |
| 시술 | rhytidectomy
|
안면거상술 | dict | 2 | |
| 시술 | genioplasty
|
턱끝성형술 | dict | 2 | |
| 재료 | poly-l-lactic acid
|
폴리락트산 | dict | 2 | |
| 합병증 | facial
|
scispacy | 1 | ||
| 약물 | deoxycholic acid
|
C0011479
deoxycholic acid
|
scispacy | 1 | |
| 약물 | [BACKGROUND]
|
scispacy | 1 | ||
| 약물 | [OBJECTIVES]
|
scispacy | 1 | ||
| 약물 | [RESULTS] A
|
scispacy | 1 | ||
| 약물 | neurotoxin
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] Cosmetic facial injectables
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | Patient
|
scispacy | 1 | ||
| 기타 | neurotoxin,
|
scispacy | 1 |
MeSH Terms
Adult; Cosmetic Techniques; Cosmetics; Deoxycholic Acid; Humans; Neurotoxins; Rejuvenation; Retrospective Studies; Surgery, Plastic
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Aesthetically ideal noses created using a single artificial intelligence model: Validating literature and exploring ethnic differences.
- Septocolumellar strut technique: Tip stability and aesthetic outcomes in rhinoplasty.
- Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.
- Mohs Surgery Defect Closure Using Blepharoplasty.